As you know DR-70 even though FDA approved is not even close to the Recaf results. This is why it would not be selling.
As far as HAAH. While it appears to be a good marker, it is represented by a small company and if not FDA approved would have to navigate the smaller markets.
IMO Dr. Moro has taken the high road with Recaf. Sales should not be a problem. Especially if he gets FDA approval through Abbott or Inverness.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.